Literature DB >> 10406554

Renal osteodystrophy in pre-dialysis patients: ethnic difference?

S K Shin1, D H Kim, H S Kim, K T Shin, K A Ma, S J Kim, Y S Kwak, S K Ha, D J Sherrard.   

Abstract

The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of renal osteodystrophy between Asian and Western countries in end-stage renal disease (ESRD) patients. We evaluated bone histology in 58 pre-dialysis patients (28 male, 30 female; mean age: 47.7 years). All patients had bone biopsies with quantitative histomorphometry and serological parameters such as intact PTH, osteocalcin, total alkaline phosphatase, and basal and deferoxamine-stimulated serum aluminum levels. We observed that 91.4% of all evaluated patients showed renal osteodystrophy before the start of dialytic therapy. Mild osteitis fibrosa were observed in 21 patients (36.2%), severe osteitis fibrosa in 5 patients (8.6%), mixed lesions in 7 patients (12.1%), osteomalacia in 6 patients (10.3%), aplastic bone disease in 14 patients (24.1%), and normal bone in 5 patients (8.6%). Among the bone histomorphometric parameters, fibrosis area rate (%) showed the best correlation with intact PTH, and osteocalcin and osteoid area rate (%) with total alkaline phosphatase. Aluminum-related bone disease was not observed. Among patients with aplastic bone disease, only 14.3% showed aluminum deposition of any significance (5% < stainable bone surface aluminum < 25%). In the diabetic patients, aplastic bone disease was most common, but no case was related to aluminum intoxication. In conclusion, the distribution of renal osteodystrophy in our study was different from that of Western countries in pre-dialysis patients. Our patients tended to have more mild-form osteitis fibrosa and normal findings, and less severe-form osteitis fibrosa and aplastic bone disease. Aluminum-related bone disease was not observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406554

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

Review 1.  Role of bone biopsy in stages 3 to 4 chronic kidney disease.

Authors:  Anca Gal-Moscovici; Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 2.  Bone health and vascular calcification relationships in chronic kidney disease.

Authors:  Goce B Spasovski
Journal:  Int Urol Nephrol       Date:  2007-09-26       Impact factor: 2.370

3.  Bone Histo-Morphology in Chronic Kidney Disease Mineral Bone Disorder.

Authors:  Khuraijam Bembem; Tejinder Singh; Narinder Pal Singh; Alpana Saxena; Shyama Lata Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-28       Impact factor: 0.900

4.  Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients.

Authors:  Gülcan Güneş; Nil Doğruer Ünal; Gülçin Eskandari; Ahmet Kiykim; Özlem Bölgen Çimen; Gülhan Temel; Mehmet Burak Y Çimen
Journal:  Int Urol Nephrol       Date:  2018-04-11       Impact factor: 2.370

5.  Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Seung Hyeok Han; Kyu Beck Lee; Joongyub Lee; Kook Hwan Oh; Dong Wan Chae; Soo Wan Kim
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.